Literature DB >> 17307082

Switching to aromatase inhibitors in early breast cancer.

Francesco Boccardo1, Alessandra Rubagotti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17307082     DOI： 10.1016/S0140-6736(07)60201-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Knockdown of eIF4E suppresses cell growth and migration, enhances chemosensitivity and correlates with increase in Bax/Bcl-2 ratio in triple-negative breast cancer cells.

Authors:  Fei-fei Zhou; Min Yan; Gui-fang Guo; Fang Wang; Hui-juan Qiu; Fei-meng Zheng; Yan Zhang; Qiang Liu; Xiao-feng Zhu; Liang-ping Xia
Journal:  Med Oncol       Date:  2010-07-22       Impact factor: 3.064

2.  Stopping treatment can reverse acquired resistance to letrozole.

Authors:  Gauri J Sabnis; Luciana F Macedo; Olga Goloubeva; Adam Schayowitz; Angela M H Brodie
Journal:  Cancer Res       Date:  2008-06-15       Impact factor: 12.701

3.  Up-regulation of kin17 is essential for proliferation of breast cancer.

Authors:  Tao Zeng; Hongyi Gao; Pei Yu; Heng He; Xiaoming Ouyang; Lijuan Deng; Yan Zhang
Journal:  PLoS One       Date:  2011-09-29       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.